Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2000-4-3
pubmed:abstractText
In follicular lymphoma, bcl-2 is translocated to the immunoglobulin heavy chain locus leading to deregulation of bcl-2 expression. We examined the role of Myb proteins in the regulation of bcl-2 expression in lymphoma cells. We showed that A-Myb up-regulates bcl-2 promoter activity. Northern and Western analyses demonstrated that A-Myb was expressed in the DHL-4 t(14;18) cell line. In t(14;18) cells and mature B cells, A-Myb up-regulated bcl-2 expression, whereas B- and c-Myb had little effect on bcl-2 gene expression. Deletion analysis of the bcl-2 5'-region identified a region responsive to A-Myb in t(14;18) cells. A potential binding site for the Cdx homeodomain proteins was located in this sequence. Analysis of the A-Myb-responsive region by UV cross-linking experiments revealed that a 32-kDa protein formed a complex with this region, but direct binding by Myb proteins could not be demonstrated. A-Myb could be recovered along with Cdx2 when nuclear extracts were passed over the Cdx site. Mutagenesis of the Cdx binding site abolished binding by the 32-kDa protein and significantly reduced the ability of A-Myb to induce bcl-2 expression. A strong induction of bcl-2 P2 promoter activity was observed in cotransfection studies of DHL-4 cells with the A-Myb and Cdx2 expression vectors, and increased endogenous Bcl-2 protein expression was observed in B cells transfected with A-Myb and/or Cdx2 expression constructs.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0021-9258
pubmed:author
pubmed:issnType
Print
pubmed:day
3
pubmed:volume
275
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
6499-508
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:10692454-Animals, pubmed-meshheading:10692454-B-Lymphocytes, pubmed-meshheading:10692454-Binding Sites, pubmed-meshheading:10692454-DNA-Binding Proteins, pubmed-meshheading:10692454-Gene Expression Regulation, Neoplastic, pubmed-meshheading:10692454-Homeodomain Proteins, pubmed-meshheading:10692454-Humans, pubmed-meshheading:10692454-Lymphoma, Follicular, pubmed-meshheading:10692454-Mutagenesis, pubmed-meshheading:10692454-Promoter Regions, Genetic, pubmed-meshheading:10692454-Proto-Oncogene Proteins, pubmed-meshheading:10692454-Proto-Oncogene Proteins c-bcl-2, pubmed-meshheading:10692454-RNA, Messenger, pubmed-meshheading:10692454-Rats, pubmed-meshheading:10692454-Trans-Activators, pubmed-meshheading:10692454-Transfection, pubmed-meshheading:10692454-Translocation, Genetic, pubmed-meshheading:10692454-Tumor Cells, Cultured, pubmed-meshheading:10692454-Ultraviolet Rays, pubmed-meshheading:10692454-Up-Regulation
pubmed:year
2000
pubmed:articleTitle
A-Myb up-regulates Bcl-2 through a Cdx binding site in t(14;18) lymphoma cells.
pubmed:affiliation
Center for Molecular Biology in Medicine, Veterans Affairs Palo Alto Health Care System and the Department of Medicine, Stanford University School of Medicine, Stanford, California 94305, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't